These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Sex-Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient-Level Pooled Analysis From 4 Postapproval Studies. Chandiramani R; Cao D; Claessen BE; Sorrentino S; Guedeney P; Blum M; Goel R; Roumeliotis A; Krucoff M; Kozuma K; Ge J; Seth A; Makkar R; Bangalore S; Bhatt DL; Angiolillo DJ; Ruster K; Wang J; Saito S; Neumann FJ; Hermiller J; Valgimigli M; Mehran R J Am Heart Assoc; 2020 Apr; 9(7):e014611. PubMed ID: 32223396 [TBL] [Abstract][Full Text] [Related]
7. Transradial vs. Transfemoral Percutaneous Coronary Intervention in Patients With or Without High Bleeding Risk Criteria. Yamamoto K; Natsuaki M; Morimoto T; Shiomi H; Watanabe H; Yamaji K; Watanabe H; Kato T; Saito N; Ando K; Kadota K; Furukawa Y; Kimura T; Circ J; 2020 Apr; 84(5):723-732. PubMed ID: 32188831 [TBL] [Abstract][Full Text] [Related]
8. Association between the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome. Shimono H; Tokushige A; Kanda D; Ohno A; Hayashi M; Fukuyado M; Akao M; Kawasoe M; Arikawa R; Otsuji H; Chaen H; Okui H; Oketani N; Ohishi M J Cardiol; 2023 Jun; 81(6):553-563. PubMed ID: 36682715 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of the Academic Research Consortium for High Bleeding Risk Criteria and Prognostic Value of a Simplified Definition. Miura K; Shimada T; Ohya M; Murai R; Amano H; Kubo S; Tada T; Tanaka H; Fuku Y; Goto T; Kadota K Circ J; 2020 Aug; 84(9):1560-1567. PubMed ID: 32669530 [TBL] [Abstract][Full Text] [Related]
10. Comparison and Validation of Long-Term Bleeding Events for Academic Bleeding Risk (ARC-HBR) Criteria and Contemporary Risk Scores for Percutaneous Coronary Intervention With a Second-Generation Drug Eluting Stent. Okabe K; Miura K; Shima Y; Ikuta A; Taguchi Y; Takahashi K; Osakada K; Ohya M; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K Circ J; 2022 Aug; 86(9):1379-1387. PubMed ID: 35400715 [TBL] [Abstract][Full Text] [Related]
11. Contribution of ESC DAPT guideline-endorsed high thrombotic risk features to long-term clinical outcomes among patients with and without high bleeding risk after PCI. Wang HY; Dou KF; Yin D; Zhang D; Gao RL; Yang YJ BMC Cardiovasc Disord; 2020 Jul; 20(1):313. PubMed ID: 32611318 [TBL] [Abstract][Full Text] [Related]
12. Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients. Cao D; Mehran R; Dangas G; Baber U; Sartori S; Chandiramani R; Stefanini GG; Angiolillo DJ; Capodanno D; Urban P; Morice MC; Krucoff M; Goel R; Roumeliotis A; Sweeny J; Sharma SK; Kini A J Am Coll Cardiol; 2020 Jun; 75(21):2711-2722. PubMed ID: 32466887 [TBL] [Abstract][Full Text] [Related]
13. Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese Percutaneous Coronary Intervention Studies. Yoshikawa Y; Shiomi H; Watanabe H; Natsuaki M; Kondo H; Tamura T; Nakagawa Y; Morimoto T; Kimura T Circulation; 2018 Feb; 137(6):551-562. PubMed ID: 28982692 [TBL] [Abstract][Full Text] [Related]
14. Applicability of the Academic Research Consortium for High Bleeding Risk in acute coronary syndrome undergoing percutaneous coronary intervention. Abu-Assi E; Raposeiras-Roubín S; Cespón Fernández M; Caneiro Queija B; Melendo Viu M; Íñiguez Romo A Rev Esp Cardiol (Engl Ed); 2022 May; 75(5):375-383. PubMed ID: 33865751 [TBL] [Abstract][Full Text] [Related]
15. Validation of the academic research consortium high bleeding risk criteria in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis of 10 studies and 67,862 patients. Silverio A; Di Maio M; Buccheri S; De Luca G; Esposito L; Sarno G; Vecchione C; Galasso G Int J Cardiol; 2022 Jan; 347():8-15. PubMed ID: 34774882 [TBL] [Abstract][Full Text] [Related]
16. Incidence and outcomes of high bleeding risk patients with type 1 and type 2 myocardial infarction in a community-based cohort: Application of the Academic Research Consortium High Bleeding Risk Criteria. Breen TJ; Raphael CE; Ingraham B; Lane C; Huxley S; Roger VL; Jaffe A; Lewis B; Sandoval YB; Prasad A; Rihal CS; Gulati R; Singh M Int J Cardiol; 2024 Feb; 396():131565. PubMed ID: 37913957 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of the Japanese high bleeding risk criteria and its prognostic significance for fatal bleeding in patients with acute myocardial infarction. Sotomi Y; Hikoso S; Nakatani D; Suna S; Dohi T; Mizuno H; Okada K; Kida H; Oeun B; Sunaga A; Sato T; Kitamura T; Sakata Y; Sato H; Hori M; Komuro I; Sakata Y; Heart Vessels; 2021 Oct; 36(10):1484-1495. PubMed ID: 33743047 [TBL] [Abstract][Full Text] [Related]
18. Sex-Based Differences in Bleeding Risk After Percutaneous Coronary Intervention and Implications for the Academic Research Consortium High Bleeding Risk Criteria. Spirito A; Gragnano F; Corpataux N; Vaisnora L; Galea R; Svab S; Gargiulo G; Siontis GCM; Praz F; Lanz J; Billinger M; Hunziker L; Stortecky S; Pilgrim T; Capodanno D; Urban P; Pocock S; Mehran R; Heg D; Windecker S; Räber L; Valgimigli M J Am Heart Assoc; 2021 Jun; 10(12):e021965. PubMed ID: 34098740 [TBL] [Abstract][Full Text] [Related]
19. High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry. Nakamura M; Kadota K; Nakao K; Nakagawa Y; Shite J; Yokoi H; Kozuma K; Tanabe K; Iijima R; Harada A; Kuroda T; Murakami Y EuroIntervention; 2021 Feb; 16(14):1154-1162. PubMed ID: 32624464 [TBL] [Abstract][Full Text] [Related]
20. Validation of the Domestic High Bleeding Risk Criteria for Japanese Patients with Acute Myocardial Infarction. Matsumoto T; Saito Y; Sato T; Yamashita D; Suzuki S; Saito K; Wakabayashi S; Kitahara H; Sano K; Kobayashi Y J Atheroscler Thromb; 2023 Mar; 30(3):299-309. PubMed ID: 35613875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]